Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
<p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in t...
Saved in:
Main Authors: | Meng-Lan Wang (Author), Dong-Mei Zhang (Author), En-Qiang Chen (Author) |
---|---|
Format: | Book |
Published: |
Archives of Hepatitis Research - Peertechz Publications,
2017-05-29.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
by: En-Qiang Chen
Published: (2015) -
Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C
by: MI Naga, et al.
Published: (2019) -
Meta-Analysis of Risk Factors for Development of Liver Cirrhosis in Chronic Hepatitis B Patients
by: Gaofeng Cai, et al.
Published: (2018) -
Constipation
Published: (2019) -
Hepatotoxicity after Sevoflurane Exposure in a Patient with Chronic Hepatitis C
by: Nickul N Shah, et al.
Published: (2015)